Article Information
History
- October 24, 2022.
Article Versions
- Version 1 (October 4, 2022 - 17:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Niklas Bobrovitz1,2,3,†,
- Harriet Ware3,
- Xiaomeng Ma4,
- Zihan Li3,5,
- Reza Hosseini3,6,
- Christian Cao1,3,
- Anabel Selemon3,
- Mairead Whelan3,
- Zahra Premji7,
- Hanane Issa8,
- Brianna Cheng1,
- Laith J. Abu Raddad9,
- David Buckeridge10,
- Maria Van Kerkhove11,
- Vanessa Piechotta12,
- Melissa Higdon13,
- Annelies Wilder-Smith14,
- Isabel Bergeri11,
- Daniel Feikin14,
- Rahul K. Arora3,15,*,
- Minal Patel14,* and
- Lorenzo Subissi11,*,†
- 1Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
- 2Department of Critical Care Medicine, University of Calgary, Canada
- 3Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Canada
- 4Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada
- 5Department of Bioengineering, University of California, Berkeley, United States of America
- 6School of Population and Public Health, University of British Columbia, Vancouver, Canada
- 7Libraries, University of Victoria, Victoria, Canada
- 8Institute of Health Informatics, University College London, United Kingdom
- 9Infectious Disease Epidemiology Group, Weill Cornell Medicine–Qatar, Cornell University, Doha, Qatar
- 10Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montreal, Canada
- 11Health Emergencies Programme, World Health Organization, Geneva, Switzerland
- 12Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
- 13International Vaccine Access Center, Department of International Health, John Hopkins Bloomberg School of Public Health, Baltimore, United States of America
- 14Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
- 15Institute of Biomedical Engineering, University of Oxford, United Kingdom
- ↵†Address correspondence to: niklas.bobrovitz{at}mail.utoronto.ca, Medical Sciences Building, 1 King’s College Circle, Toronto, Canada, M5S 1A8 Or subissil{at}who.int, World Health Organization, Avenue Appia 20, Geneva, Switzerland, CH1211
↵* contributed equally